Analytical Data
-
Gene name
A1BG
- Application
-
Alternative Names
A1BG；Alpha-1B-glycoProtein
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P04217-2
-
Expression Region
1-373aa
-
AA Sequence
MAPVSWITPGLKTTAVCRGVLRGVTFLLRREGDHEFLEVPEAQEDVEATF PVHQPGNYSCSYRTDGEGALSEPSATVTIEELAAPPPPVLMHHGESSQVL HPGNKVTLTCVAPLSGVDFQLRRGEKELLVPRSSTSPDRIFFHLNAVALG DGGHYTCRYRLH DNQNGWSGDSAPVELILSDETLPAPEFSPEPESGRA LRLRCLAPLEGARFALVREDRGGRRVHRFQSPAGTEALFELHNISVADSA NYSCVYVDLKPPFGGSAPSERL ELHVDGPPPRPQLRATWSGAVLAGRD AVLRCEGPIPDVTFELLREGETKAVKTVRTPGAAANLELIFVGPQHAGNY RCRYRSWVPHTFESELSDPVELLVAES
-
Molecular Weight
67 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
A1BG (alpha-1B-glycoprotein) is a liver-derived glycoprotein that plays a significant role in various biological processes, including immune response, inflammation, and metabolism. Originally identified as a serum protein, recent studies have highlighted its potential implications in disease states, such as cancer progression and cardiovascular disorders. The interest in A1BG has surged due to its tissue-specific expression patterns and its involvement in cellular signaling pathways. Recombinant A1BG protein has become an essential tool for researchers aiming to elucidate its functional roles and mechanisms of action. By producing A1BG in a controlled laboratory setting, scientists can investigate its biochemical properties, interactions with other proteins, and effects on cell signaling. Moreover, understanding A1BG's structure-function relationship could pave the way for developing novel therapeutic strategies targeting diseases associated with its dysregulation. As research progresses, A1BG is increasingly recognized not only as a biomarker for certain health conditions but also as a potential therapeutic target, highlighting the importance of developing robust methods for obtaining and studying recombined A1BG proteins.
